🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on October 14 at age 51 after a personal fight with pancreatic cancer.

“The brilliant light of our family has faded away for us in the present world,” his relatives stated. “After a lengthy and courageous battle with the disease, we are deeply saddened to announce that D’Angelo, known to his fans around the world as D’Angelo, has been called home.”

D’Angelo left an indelible mark on music with his innovative modern soul style and partnerships with renowned musicians.

He launched his debut album, “Brown Sugar,” in 1995 to instant praise. The record achieved No. 4 on Billboard’s Top R&B Albums chart, went platinum later that year, and earned several award nominations.

However, it was his second album, “Voodoo,” in 2000 that propelled his music career into the limelight. The album premiered at No. 1 on both Billboard’s Top R&B Albums chart and the main album chart. He won two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a reluctant one, in the public consciousness. The personal depiction showed the singer, notably bare to his waist, performing straight into the camera.

D’Angelo stepped back from the public eye after putting out Voodoo and publicly struggled with drugs and alcohol. In 2005, he was part of a serious vehicle accident that put him in grave health.

Over ten years later, his third and final album, “Black Messiah” (2014), reaffirmed his lasting popularity with another No. 1 debut on the R&B chart and a award for Top R&B Record.

Once more, in his own mysterious way, D’Angelo had limited public outings in the following years.

The musician was announced as a headliner for the 2025 music event, but his appearance was canceled, due to an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s well-being in the months leading up to his passing, he had apparently been in the hospital for months and in hospice for two weeks.

D’Angelo’s demise is a clear example of the devastating effects of pancreatic cancer, one of the most deadly and least preventable types of the disease, on a brilliant talent whose life was ended too soon.

“We are grieved that he can only leave cherished moments with his family, but we are eternally grateful for the legacy of extraordinarily moving music he leaves behind,” his family said.

Pancreatic Cancer: Lethal and Rarely Preventable

Pancreatic malignancy impacts the pancreas, a tiny gland that produces the hormone insulin and is vital in breaking down food, among additional roles. The position and dimensions of the organ in the body make it more challenging to identify cancer.

Although pancreatic cancer accounts for only approximately three percent of malignancy cases each year in the U.S., it is responsible for seven percent of malignancy fatalities.

Nearly 70,000 individuals will be diagnosed with this condition and roughly fifty-two thousand will succumb to the disease in the year 2025.

“This malignancy is one of the most lethal diseases, with an fast-growing mass and poor prognosis. We have limited and ineffective therapies, and a narrow opportunity to make a meaningful impact on the well-being of patients,” noted a cancer specialist.

Since pancreatic cancer rarely causes early symptoms, it’s often identified only once the condition is advanced. Although a patient has symptoms they are often vague and may be mistaken for a several everyday ailments.

“Currently, there is no good way to identify this malignancy in the initial phases, except for paying attention to physical changes and speaking with your physician if there are unfamiliar symptoms,” explained a medical director.

Frequent indicators of pancreatic cancer include:

• abdominal or lower back pain
• reduced body mass
• jaundice
• reduced hunger
• dark urine
• light-colored or greasy stools
• diarrhea
• increased appetite or thirst
• nausea

At 51 years old, D’Angelo’s demise is an exception, as pancreatic cancer is most common in individuals in the 65 to 75 age bracket. However, numerous malignancies, such as this type, have become more common in younger adults.

“This disease diagnosed prior to fifty is deemed uncommon, yet concerningly, doctors are beginning to see a rising count of younger patients affected by this disease,” said a expert.

Family History Impacts Cancer Risk

Without effective screening tools for this malignancy, experts stressed the significance of understanding your family’s cancer history. Certain contributing elements, such as tobacco use and excess weight also play a role in the development of this disease.

Black individuals have the greatest occurrence of pancreatic cancer in the U.S. and are most likely to be found to have inoperable cancer.

“The first step toward reducing one’s risk of this condition is understanding personal risk factors. People should examine their genetic background, hereditary factors, and health issues, such as diabetes, long-term pancreas inflammation, or overweight that may raise their vulnerability,” said a specialist.

Inherited genetic elements are linked to as much as 10% of all pancreatic cancer instances. If a relative in your household has had pancreatic cancer, you may want to consider genetic testing.

“For individuals with a family history of pancreatic cancer or those having elevated risk DNA changes, checking may involve advanced imaging such as magnetic resonance imaging (MRI) or internal ultrasound to detect early changes in the organ,” he explained.

For those looking to reduce their risk, habit adjustments may make a difference. The most effective action you can take to reduce your susceptibility of this disease is to stop tobacco use, and if you are a non-smoker, stay away altogether.

Excessive alcohol consumption is associated with pancreatitis, a risk factor for pancreatic cancer, so reducing or avoiding drinks may assist reduce your risk.

Managing your body mass or losing weight may also aid decrease your susceptibility. People with obesity are 20% more likely to get this disease. Pancreatic cancer also occurs more often in people with diabetes, and reducing weight can also reduce the risk of adult-onset diabetes.

In spite of this disease’s grim outlook, there is reason for optimism.

“We are making progress with treatments and more recent combination chemotherapy. There are emerging targeted therapies that are already showing results,” said a specialist.

For many individuals, however, education about this uncommon but {dev